Skip to main content
. 2021 Apr 7;11:7614. doi: 10.1038/s41598-021-87289-6

Figure 1.

Figure 1

Schematic overview of samples and antibody detection tests. IFA immunofluorescence assay. *32/72 samples collected 1–21 days post symptom onset, 65/129 samples collected ≥ 22 days post symptom onset, and 7/19 samples lacking information regarding elapsed time between symptom onset and sampling.126/129 samples collected ≥ 22 days post symptom onset.15/72 samples collected 1–21 days and 94/129 samples collected ≥ 22 days post symptom onset.